We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.FORM OF EXECUTIVE RETENTION AGREEMENTExecutive Retention Agreement • February 27th, 2024 • Supernus Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
Contract Type FiledFebruary 27th, 2024 Company Industry JurisdictionTHIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”) is made and entered into this [·] day of [·], [·] (the “Effective Date”) by and between Supernus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and [·] (the “Executive”).
EXECUTIVE RETENTION AGREEMENTExecutive Retention Agreement • October 5th, 2020 • Supernus Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
Contract Type FiledOctober 5th, 2020 Company Industry JurisdictionTHIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”) is made and entered into this 12th day of October 2020 (the “Effective Date”) by and between Supernus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and James P. Kelly (the “Executive”).
EXECUTIVE RETENTION AGREEMENTExecutive Retention Agreement • September 18th, 2014 • Supernus Pharmaceuticals Inc • Pharmaceutical preparations • Maryland
Contract Type FiledSeptember 18th, 2014 Company Industry JurisdictionTHIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”) is made and entered into this [·] day of [·], 2014 (the “Effective Date”) by and between Supernus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and [·] (the “Executive”).
EXECUTIVE RETENTION AGREEMENTExecutive Retention Agreement • August 11th, 2014 • Supernus Pharmaceuticals Inc • Pharmaceutical preparations • Maryland
Contract Type FiledAugust 11th, 2014 Company Industry JurisdictionTHIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”) is made and entered into this [DATE] day of [MONTH], 2014 (the “Effective Date”) by and between Supernus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and [EMPLOYEE NAME] (the “Executive”).